Abstract Background and Aims Chronic kidney disease (CKD) is a leading cause of global morbidity mortality independently associated with cardiovascular disease. Indeed, patients CKD are more likely to die than they progress failure. Despite current standard care, outcomes remain poor newer therapies needed. Apelin, an endothelium-dependent vasodilator potent inotrope, potential novel treatment ...